Home > Insider Trading > Legend Biotech Corporation

Legend Biotech Corporation (LEGN)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

10 Best Up and Coming Stocks To Buy According to Analysts

Donald Trump's victory in the recent presidential election is expected to encourage companies that have been hesitant to pursue IPOs in 2025, capitalizing on the positive market reaction and anticipated...

Keep Reading →

November 26th, 2024 - Hedge Funds News

10 Worst Performing Biotech Stocks in 2024

Biotechnology stocks are among the most volatile in the market due to their high risk.

Keep Reading →

November 21st, 2024 - Hedge Funds News

12 NASDAQ Stocks with Biggest Upside Potential According to Analysts

Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.

Keep Reading →

November 21st, 2024 - Hedge Funds News

Legend Biotech Corporation (NASDAQ:LEGN) Q3 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2024 Financial Results. At this time, all participants are in a listen-only mode.

Keep Reading →

November 13th, 2024 - News Transcripts

10 Most Promising Biotech Stocks According to Hedge Funds

Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.

Keep Reading →

October 11th, 2024 - Hedge Funds Industries News

Here's Why TimesSquare Capital Management U.S. Focus Growth Strategy Removed Legend Biotech Corporation (LEGN) from its Portfolio

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” second-quarter 2024 investor letter.

Keep Reading →

September 12th, 2024 - Hedge Fund Investor Letters News

10 Largest Biotech Hedge Funds and Their Top Stock Picks

The ability to successfully make money through investment requires deep thinking and analysis.

Keep Reading →

September 11th, 2024 - Hedge Funds News

Ray Dalio’s Top 10 Growth Stock Picks with 30+% Revenue Growth

Valuing a stock comes in several shapes and flavors. The most common of these is the price to earnings ratio.

Keep Reading →

July 29th, 2024 - Hedge Funds News

Does Legend Biotech (LEGN) Have a Long Runway for Growth?

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” first-quarter investor letter. A copy of the letter can be downloaded here.

Keep Reading →

June 24th, 2024 - Hedge Fund Investor Letters News